The efficacy and toxicity profile of metronomic chemotherapy for metastatic breast cancer: A meta-analysis.

The current meta-analysis aimed to summarize the available evidence for the efficacy and serious adverse events (AEs) associated with use of metronomic chemotherapy (MCT) in patients with metastatic breast cancer (MBC).Electronic databases (PubMed, EMBASE database, Web of Knowledge, and the Cochrane...

Full description

Bibliographic Details
Main Authors:	Yangyang Liu, Feifei Gu, Jinyan Liang, Xiaomeng Dai, Chao Wan, Xiaohua Hong, Kai Zhang, Li Liu
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2017-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC5351982?pdf=render

Similar Items

Metronomic Chemotherapy in Triple-Negative Metastatic Breast Cancer: The Future Is Now?
by: M. E. Cazzaniga, et al.
Published: (2017-01-01)

Durable control of metastatic nasopharyngeal carcinoma with metronomic chemotherapy
by: Po-Hsiang Huang, et al.
Published: (2017-03-01)

Metronomic Chemotherapy
by: Marina Elena Cazzaniga, et al.
Published: (2021-05-01)

Metronomic chemotherapy and propranolol in a patient with metastatic angiosarcoma: Magic bullets?
by: Arun Chandrasekharan, et al.
Published: (2020-01-01)

Retrospective study of the efficacy and toxicity of lobaplatin in combined chemotherapy for metastatic breast cancer
by: Wu Y, et al.
Published: (2019-06-01)

Mechanism of cancer evading metronomic chemotherapy and action of Archazolid as an anti-metastatic drug
by: Kubisch, Rebekka
Published: (2013)

Metronomic Cyclophosphamide and Methotrexate Chemotherapy Combined with 1E10 Anti-Idiotype Vaccine in Metastatic Breast Cancer
by: Jorge L. Soriano, et al.
Published: (2011-01-01)

Metronomic chemotherapy regimens in oncology
by: M. Yu. Fedyanin, et al.
Published: (2016-04-01)

Clinical Applications of Metronomic Chemotherapy
Published: (2023)

Metronomic S-1 Chemotherapy and Vandetanib: An Efficacious and Nontoxic Treatment for Hepatocellular Carcinoma
by: Hideki Iwamoto, et al.
Published: (2011-03-01)

Metronomic chemotherapy offsets HIFα induction upon maximum‐tolerated dose in metastatic cancers
by: Luana Schito, et al.
Published: (2020-09-01)

Metronomic capecitabine as extended adjuvant chemotherapy in women with triple negative breast cancer
by: H.A. Alagizy, et al.
Published: (2015-03-01)

Metronomic palliative chemotherapy in maxillary sinus tumor
by: Vijay M Patil, et al.
Published: (2016-01-01)

Ciclooxygenase inhibitor and metronomic chemotherapy association for the treatment of metastatic anal sac carcinoma in dog: case report
by: N.C.T. Teixeira, et al.
Published: (2016-08-01)

Gut Microbiota Profiling in Patients With HER2-Negative Metastatic Breast Cancer Receiving Metronomic Chemotherapy of Capecitabine Compared to Those Under Conventional Dosage
by: Xiuwen Guan, et al.
Published: (2020-07-01)

Metronomic Chemotherapy with Cyclophosphamide and Piroxicam in Dogs with Malignant Tumors
by: Yung-Ching Chang, et al.
Published: (2019)

Mathematical model of cancer growth controled by metronomic chemotherapies*
by: André N., et al.
Published: (2013-12-01)

Trastuzumab in combination with metronomic cyclophosphamide and methotrexate in patients with HER-2 positive metastatic breast cancer
by: Orlando Laura, et al.
Published: (2006-09-01)

Suppressive impact of metronomic chemotherapy using UFT and/or cyclophosphamide on mediators of breast cancer dissemination and invasion.
by: Raquel Muñoz, et al.
Published: (2019-01-01)

Treating advanced breast cancer with metronomic chemotherapy: what is known, what is new and what is the future?
by: Cazzaniga ME, et al.
Published: (2019-04-01)

A study of capecitabine metronomic chemotherapy is non-inferior to conventional chemotherapy as maintenance strategy in responders after induction therapy in metastatic colorectal cancer
by: Min Shi, et al.
Published: (2020-03-01)

Salvage Surgery for Metastatic Gall Bladder Cancer with Vanishing Liver Metastasis Following Palliative 5-Fluorouracil Metronomic Chemotherapy
by: RDR Somasekar, et al.
Published: (2017-05-01)

Use of metronomic chemotherapy in the management of a cat with abdominal haemangiosarcoma
by: Katrina Yee-Ka Cheng, et al.
Published: (2018-08-01)

Can metronomic chemotherapy be an alternative to sorafenib in advanced hepatocellular carcinoma?
by: Do Young Kim
Published: (2017-06-01)

Anti-Angiogenic Effect of Orally Available Pemetrexed for Metronomic Chemotherapy
by: Ruby Maharjan, et al.
Published: (2019-07-01)

Metronomic Chemotherapy: A Systematic Review of the Literature and Clinical Experience
by: Cem Simsek, et al.
Published: (2019-01-01)

METRONOMIC CHEMOTHERAPY: ROLE IN DEVELOPING COUNTRIES FOR HEAD AND NECK CANCER
by: Manish Devendra Mair, et al.
Published: (2017-04-01)

Efficacy and tolerability of Sorafenib plus metronomic chemotherapy S-1 for advanced hepatocellular carcinoma in preclinical and clinical assessments
by: Hiroyuki Suzuki, et al.
Published: (2021-11-01)

Efficacy and Toxicity of Metronomic Oral Vinorelbinen in Advanced Non-small Cell Lung Cancer after Failure to Multiple-lines Treatments
by: Shuyang YAO, et al.
Published: (2017-11-01)

An individual patient-data meta-analysis of metronomic oral vinorelbine in metastatic non-small cell lung cancer.
by: Jean-Louis Pujol, et al.
Published: (2019-01-01)

Weekly paclitaxel as metronomic palliative chemotherapy in small cell lung cancer
by: Vanita Noronha, et al.
Published: (2016-01-01)

Metronomic Chemotherapy: Seems Prowess to Battle against Cancer in Current Scenario
by: Prema Muthusamy, et al.
Published: (2016-11-01)

Metronomic Chemotherapy Combined with Dendritic Cell Vaccine  Inhibits VEGF Secretion
by: Yan ZHOU, et al.
Published: (2013-09-01)

Serum levels of VEGF and MCSF in HER2+ / HER2- breast cancer patients with metronomic neoadjuvant chemotherapy
by: Roberto J. Arai, et al.
Published: (2018-06-01)

Metronomic Chemotherapy - A New Path to Treat Advanced Non-small Cell Lung Cancer
by: Shuang ZHANG, et al.
Published: (2015-04-01)

Therapeutic efficacy and toxicity of bolus application of chemotherapy protocol in the treatment of metastatic colorectal cancer
by: Ibrahim Šišić, et al.
Published: (2015-08-01)

Individually Tailored Toxicity-based Chemotherapy : Studies on Patients with Primary and Metastatic Breast Cancer
by: Lindman, Henrik
Published: (2003)

Efficacy and Safety of the All-Oral Schedule of Metronomic Vinorelbine and Capecitabine in Locally Advanced or Metastatic Breast Cancer Patients: The Phase I-II VICTOR-1 Study
by: M. E. Cazzaniga, et al.
Published: (2014-01-01)

Efficacy of bevacizumab combined with chemotherapy in the treatment of HER2-negative metastatic breast cancer: a network meta-analysis
by: Zhengwu Sun, et al.
Published: (2020-03-01)

An audit of the results of a triplet metronomic chemotherapy regimen incorporating a tyrosine kinase inhibitor in recurrent/metastatic head and neck cancers patients
by: Vijay M Patil, et al.
Published: (2016-01-01)